Search results for: “keytruda”
-
Blog
Keytruda Receives 40th FDA Approval
This week marked a significant milestone in the fight against cancer. On June 17, the FDA approved… -
Blog
FDA approves Keytruda combo for first-line lung cancer treatment
Patients in the U.S. who have advanced nonsquamous non-small cell lung cancer can now receive Keytruda as…
-
Blog
Pembrolizumab (Keytruda®) Approved as First-Line Option for Lung Cancer
Anti-PD-1 checkpoint antibody is the only immunotherapy approved for first-line treatment for lung cancer patients.
-
Blog
FDA Approves Pembrolizumab (Keytruda®), a PD-1 Antibody, for Head and Neck Cancer
New hope now exists for patients with advanced head and neck cancer.
-
Blog
European Regulators Approve Pembrolizumab (Keytruda) as First-line Treatment of Advanced Melanoma
The decision makes pembrolizumab the second PD-1-blocking drug to receive approval in Europe.
-
Media Room Article
First-Ever Treatments, Faster Paths to Approval, and a Shift in Global Drug Development Define the State of Cancer Immunotherapy in 2025, New Report Finds
Cancer Research Institute’s (CRI) annual Cancer Immunotherapy Insights & Impact report tracks 13 new FDA approvals and… -
Page
2026 Cancer Immunotherapy Insights + Impact Report
Foreword Over three decades ago, when I started my work in cancer research, I was driven by… -
Page
2025 Cancer Immunotherapy Insights + Impact Report
Executive Summary The Cancer Research Institute (CRI) Cancer Immunotherapy Insights and Impact report provides a comprehensive analysis… -
Page
A Patient’s Guide to Immunotherapy for Colorectal Cancer
A Patient’s Guide to Cancer Immunotherapy Colorectal Cancer What You Need to Know Hearing the words “You…